Literature DB >> 12030525

Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length.

William J Groh1, Miriam R Lowe, Douglas P Zipes.   

Abstract

INTRODUCTION: Cardiac myopathy manifesting with conduction disturbances and arrhythmias is common in the neurologic disease myotonic dystrophy. We studied whether the severity of cardiac involvement in myotonic dystrophy correlates with the severity of the genetic abnormality cytosine-thymine-guanine (CTG) repeat expansion. METHODS AND
RESULTS: History, physical examination, ECG evaluation, and genetic testing were performed in patients with a clinical diagnosis of myotonic dystrophy. In 342 of 385 patients, the diagnosis was confirmed by CTG repeat expansion. In these patients, the muscular disability severity correlated with age and CTG repeat length (r = 0.44, P < 0.001). An arrhythmia diagnosis was present in 19 (5.6%) patients with a likelihood of diagnosis correlating with age (relative risk [RR] 2.2 per decade, 95% confidence intervals [CI] 1.4 to 3.4, P = 0.001) and CTG repeat length (RR 2.9 per 500 repeats, 95% CI 1.5 to 5.4, P = 0.001). ECGs were abnormal in 222 (64.9%) of the patients. Age, CTG repeat length, and male gender were factors found to correlate with ECG conduction abnormalities quantitated by the PR interval (r = 0.43, P < 0.001) and QRS duration (r = 0.32, P < 0.001). A 24-hour ambulatory ECG was abnormal in 95 (29.6%) of 321 recordings. The presence of an abnormality correlated with age (RR 1.5 per decade, 95% CI 1.2 to 1.9, P < 0.001) and CTG repeat length (RR 1.6 per 500 repeats, 95% confidence intervals 1.1 to 2.2, P = 0.01).
CONCLUSION: The severity of skeletal and cardiac myopathy in myotonic dystrophy correlates with age and CTG repeat length, suggesting a similar mechanism causing a time-dependent degenerative process.

Entities:  

Mesh:

Year:  2002        PMID: 12030525     DOI: 10.1046/j.1540-8167.2002.00444.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  25 in total

Review 1.  Myotonic dystrophy and the heart.

Authors:  G Pelargonio; A Dello Russo; T Sanna; G De Martino; F Bellocci
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

2.  Towards an integrative approach to the management of myotonic dystrophy type 1.

Authors:  Cynthia Gagnon; Luc Noreau; Richard T Moxley; Luc Laberge; Stéphane Jean; Louis Richer; Michel Perron; Suzanne Veillette; Jean Mathieu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-20       Impact factor: 10.154

3.  Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1.

Authors:  Lukas Chmielewski; Michael Bietenbeck; Alexandru Patrascu; Sabine Rösch; Udo Sechtem; Ali Yilmaz; Anca-Rezeda Florian
Journal:  Clin Res Cardiol       Date:  2019-02-14       Impact factor: 5.460

Review 4.  Ophthalmic manifestations of inherited neurodegenerative disorders.

Authors:  Hannah M Kersten; Richard H Roxburgh; Helen V Danesh-Meyer
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

5.  Diastolic heart dysfunction is correlated with CTG repeat length in myotonic dystrophy type 1.

Authors:  Jin-Sung Park; Namkyun Kim; Donghwi Park
Journal:  Neurol Sci       Date:  2018-08-09       Impact factor: 3.307

Review 6.  Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes.

Authors:  Kevin Yum; Eric T Wang; Auinash Kalsotra
Journal:  Curr Opin Genet Dev       Date:  2017-02-14       Impact factor: 5.578

Review 7.  Mechanisms and management of the heart in myotonic dystrophy.

Authors:  Elizabeth M McNally; Dina Sparano
Journal:  Heart       Date:  2011-07       Impact factor: 5.994

8.  Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1.

Authors:  Bradley A Hardin; Miriam R Lowe; Deepak Bhakta; William J Groh
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-07       Impact factor: 1.468

9.  Dmpk gene deletion or antisense knockdown does not compromise cardiac or skeletal muscle function in mice.

Authors:  Samuel T Carrell; Ellie M Carrell; David Auerbach; Sanjay K Pandey; C Frank Bennett; Robert T Dirksen; Charles A Thornton
Journal:  Hum Mol Genet       Date:  2016-08-13       Impact factor: 6.150

10.  Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy.

Authors:  Robert Breton; Jean Mathieu
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.